Hugh Hall, DPM
Foot & Ankle Surgery · Lakeside, AZNPI 1952352619
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (36.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 46.6% of the total. Reporting peaked in 2022 at $6,107 and has fallen 91.7% since, to $505 in 2025.
Across 99 payments — averaging $99.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Stryker$2K
- Impactortho, Inc.$816
- Zimmer Biomet$708
- Paragon 28, Inc.$639
- AbbVie$292
- plus $858 from 9 others
What the payments were for
- Travel & lodging$2,99831%
- Food & beverage$3,20833%
- Education$3,60037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 19 | $4,571 |
| Stryker | 15 | $1,922 |
| Impactortho, Inc. | 7 | $816 |
| Zimmer Biomet | 9 | $708 |
| Paragon 28, Inc. | 3 | $639 |
| AbbVie | 15 | $292 |
| Ortho Solutions Inc | 3 | $279 |
| Orthofix Medical, Inc. | 13 | $202 |
| Smith+Nephew | 8 | $137 |
| Organogenesis Inc. | 2 | $83 |
| Goode Surgical Inc | 1 | $71 |
| Johnson & Johnson | 1 | $39 |
| Merck | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INBONE$982
- APEX TAR$554
- PROstep$539
- Trabecular Metal (TM)$451
How this compares
$9,806 in reported general payments places this provider in the 80th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 110 | $2,113 |
| Allopurinol | 63 | $1,793 |
| Cephalexin | 163 | $1,033 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $830 |
| Ciclopirox | 26 | $532 |
| Pregabalin | 19 | $484 |
| CiclopiroxCiclopirox Olamine | 29 | $423 |
| Ciprofloxacin Hcl | 19 | $276 |
| Mupirocin | 38 | $273 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $217 |
| Clindamycin Hcl | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lakeside
- Ryan ScottPhoenix$1.1M
- Jeffrey McAlisterScottsdale$578K
- Jeffrey HolmesPhoenix$509K
- Myron HansenChandler$480K
- Scott MalingMesa$382K
- Melissa GalliPhoenix$324K
- Geoffrey LandisTucson$307K
- Zachary FlynnPhoenix$239K
- Bruce WerberScottsdale$177K
- Keith GossChandler$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.